Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

ACS Emergency General Surgery Verification associated with fewer deaths and shorter stays (opens in a new tab)

news-medical.net · 2026-11-04

Short answerEvidenceSource

Short answer

Mixed

Mixed.

The claims we could check match the study, but some claims were not covered by the evidence reviewed.

  • 3 supported
  • 2 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mixed

Every claim we could check holds up. Three of five claims match the study. This overall rating is based only on the claims we could check. Two claims the study doesn't address.

  • 3 supported
  • 2 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

5 claims in this story

Showing all 5 claimsChoose a verdict to focus the list.

Claim 1 of 5Not coveredIn a before-and-after analysis of verified hospitals, median time from admission to surgery fell from 31.9 hours to 21.2 hours, the share of patients admitted to an emergency general surgery service rose from 74.8% to 85.7%, and the share who had surgery after unsuccessful nonsurgical treatment fell from 25.5% to 19%.View evidenceHide evidence

As stated31.9 to 21.2 hours; 74.8% to 85.7%; 25.5% to 19%

Why this verdict

The abstract-level profile supports increased admission to surgical services from 74.8% to 85.7%, decreased failure of nonoperative management from 25.5% to 19.0%, and a 10.7-hour shorter time to operation. However, it does not provide the stated baseline and follow-up time-to-surgery values of 31.9 to 21.2 hours, nor does it verify that this was a median rather than another summary measure.

1

Study evidence

Admission to surgical services increased following verification.74.8% to 85.7% (P < .001)

“Verification was also associated with improved care processes, including increased admission to surgical services (74.8% to 85.7%; P < .001), decreased failure of nonoperative management (25.5% to 19.0%; P < .001), and shorter time to operation (−10.7 hours; P < .001).”
Claim 2 of 5Not coveredThe story notes that the study reflects early results from five verified hospitals and a limited follow-up period, and that hospitals chose whether to seek verification and participate in the NSQIP data program, so other differences between hospitals or patients may have influenced the findings.View evidenceHide evidence

Why this verdict

The abstract-level profile supports some caveats: only five verified hospitals were included, the study period was short, and verified hospitals differed at baseline, including higher-acuity patients and higher predicted mortality and AKI rates. However, the supplied profile does not verify the story’s specific statement that hospitals chose whether to seek verification and participate in NSQIP, so that part is not verifiable at abstract depth.

1

Study evidence

Adoption of ACS EGS verification was associated with a reduction in mean hospital length of stay.Absolute reduction −1.31 days (95% CI −1.95 to −0.67); relative reduction 19.7%

“This quasi-experimental difference-in-differences cohort study with staggered adoption used data from the ACS National Surgical Quality Improvement Program EGS Targeted Dataset.”
2

Study evidence

Admission to surgical services increased following verification.74.8% to 85.7% (P < .001)

“Verification was also associated with improved care processes, including increased admission to surgical services (74.8% to 85.7%; P < .001), decreased failure of nonoperative management (25.5% to 19.0%; P < .001), and shorter time to operation (−10.7 hours; P < .001).”
Claim 3 of 5SupportedPatients treated at hospitals that earned American College of Surgeons Emergency General Surgery Verification had lower 30-day death rates and shorter hospital stays after their hospitals became verified, according to an analysis published in JAMA Surgery.View evidenceHide evidence

Why this verdict

The abstract-level profile supports that ACS EGS verification was associated with lower 30-day mortality and shorter mean length of stay after verification in a quasi-experimental difference-in-differences analysis. The headline is unhedged, but it frames the finding as coming from an analysis and does not clearly make a causal claim beyond the paper’s association.

1

Study evidence

Adoption of ACS EGS verification was associated with a reduction in mean hospital length of stay.Absolute reduction −1.31 days (95% CI −1.95 to −0.67); relative reduction 19.7%

“This quasi-experimental difference-in-differences cohort study with staggered adoption used data from the ACS National Surgical Quality Improvement Program EGS Targeted Dataset.”
Claim 4 of 5SupportedThe analysis included 21,858 emergency general surgery patients treated at 55 hospitals, five of which became verified during the study period.View evidenceHide evidence

As stated21,858 patients; 55 hospitals; 5 verified hospitals

Why this verdict

The paper profile reports 21,858 operatively managed EGS patients at 55 hospitals, including 5 verified hospitals and 50 control hospitals.

1

Study evidence

Adoption of ACS EGS verification was associated with a reduction in mean hospital length of stay.Absolute reduction −1.31 days (95% CI −1.95 to −0.67); relative reduction 19.7%

“This quasi-experimental difference-in-differences cohort study with staggered adoption used data from the ACS National Surgical Quality Improvement Program EGS Targeted Dataset.”
Claim 5 of 5SupportedRelative to hospitals that did not undergo verification, verification was associated with a 28.8% lower 30-day postoperative death rate, a 29% lower acute kidney injury rate, and hospital stays that averaged 1.31 fewer days, a 19.7% reduction.View evidenceHide evidence

As stated28.8% lower death rate; 29% lower acute kidney injury; 1.31 fewer days; 19.7% reduction

Why this verdict

The stated magnitudes match the abstract-level profile: 30-day mortality relative reduction 28.8%, AKI relative reduction 29.0%, and mean length of stay reduction of 1.31 days, corresponding to a 19.7% relative reduction. The claim appropriately frames these as associations relative to nonverified/control hospitals.

1

Study evidence

Adoption of ACS EGS verification was associated with a reduction in mean hospital length of stay.Absolute reduction −1.31 days (95% CI −1.95 to −0.67); relative reduction 19.7%

“This quasi-experimental difference-in-differences cohort study with staggered adoption used data from the ACS National Surgical Quality Improvement Program EGS Targeted Dataset.”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • Methodological design: quasi-experimental difference-in-differences cohort study with staggered adoption, ATT estimation, hospital-clustered bootstrap standard errors, risk adjustment, and Bonferroni correction.

    The story describes an analysis comparing verified and nonverified hospitals, but it does not convey the specific difference-in-differences/staggered-adoption design or the main inferential safeguards reported in the abstract-level profile.

    From quasi-experimental difference-in-differences (staggered adoption)

  • Secondary process-outcome interpretation: all measured processes were independently associated with improvements in the three primary outcomes, suggesting possible contribution to the observed outcome improvements.

    The story reports the process changes but does not state the paper’s additional finding that these process measures were independently associated with improvements in length of stay, AKI, and mortality.

    From registry-based staggered-adoption DID with multivariable process–outcome modeling

4 things the story did carry across
  • Primary finding: ACS EGS verification was associated with reductions in mean length of stay, acute kidney injury, and 30-day mortality.
  • Study cohort and comparison: 21,858 operatively managed EGS patients at 5 verified and 50 control hospitals using ACS NSQIP EGS Targeted Dataset data.
  • Process-measure findings: verification was associated with increased admission to surgical services, decreased failure of nonoperative management, and shorter time to operation.
  • Key limitations: only five verified hospitals were included, and verified hospitals differed at baseline, including higher-acuity patients and higher predicted mortality and AKI rates, raising residual-confounding concerns.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

2

Evidence read

study summary

Lead result

secondary data

1Lead resultsecondary dataEstimate the association between ACS Emergency General Surgery (EGS) Verification Program adoption and patient outcomes (length of stay, acute kidney injury, 30-day mortality) using a quasi-experimental difference-in-differences design.quasi-experimental difference-in-differences (staggered adoption)Expand

In plain English

Using a quasi-experimental difference-in-differences design with staggered adoption applied to the ACS NSQIP EGS Targeted Dataset (operatively managed EGS cases from July 1, 2023–Dec 31, 2024; 5 verified and 50 control hospitals; N=21,858), ACS EGS verification was associated with reductions in mean hospital length of stay (−1.31 days; 95% CI −1.95 to −0.67), acute kidney injury (−1.23 percentage points; 95% CI −2.00 to −0.46), and 30‑day mortality (−1.63 percentage points; 95% CI −2.55 to −0.71); effects persisted after risk adjustment and Bonferroni correction and were estimated as average treatment effects on the treated with hospital-clustered bootstrap standard errors.

Key findings

  • Adoption of ACS EGS verification was associated with a reduction in mean hospital length of stay.Absolute reduction −1.31 days (95% CI −1.95 to −0.67); relative reduction 19.7%
  • Adoption of ACS EGS verification was associated with a reduction in acute kidney injury (AKI) rate.Absolute reduction −1.23 percentage points (95% CI −2.00 to −0.46); relative reduction 29.0%
“This quasi-experimental difference-in-differences cohort study with staggered adoption used data from the ACS National Surgical Quality Improvement Program EGS Targeted Dataset.”
What this piece can’t prove
  • Verified hospitals differed at baseline: prior to verification, verified hospitals treated higher‑acuity patients and had higher predicted mortality and AKI rates (reported in abstract).
  • Small number of verified hospitals in the analytic set (5 verified hospitals reported in abstract).
2secondary dataAssess whether (and how) changes in care processes associated with EGS verification contribute to observed outcome improvements (process changes and their associations with LOS/AKI/mortality).registry-based staggered-adoption DID with multivariable process–outcome modelingExpand

In plain English

Using ACS NSQIP EGS Targeted Dataset data from July 1, 2023–December 31, 2024 across 55 hospitals (5 verified, 50 control), the authors report that EGS verification was associated with improvements in three pre-specified care-process measures (admission to surgical services, failure of nonoperative management, time to operation). They additionally report that each process measure was independently associated with improvements in the three primary clinical outcomes (length of stay, acute kidney injury, 30-day mortality), and interpret these process changes as a partial explanation for the observed outcome improvements.

Key findings

  • Admission to surgical services increased following verification.74.8% to 85.7% (P < .001)
  • Failure of nonoperative management decreased following verification.25.5% to 19.0% (P < .001)
“Verification was also associated with improved care processes, including increased admission to surgical services (74.8% to 85.7%; P < .001), decreased failure of nonoperative management (25.5% to 19.0%; P < .001), and shorter time to operation (−10.7 hours; P < .001).”
What this piece can’t prove
  • Only five verified hospitals were included, which may limit generalizability and precision of hospital-level process analyses.
  • Verified hospitals treated higher-acuity patients and had higher predicted mortality and AKI prior to verification, raising potential for residual confounding or differential preexisting trends.

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Open the paper in Tessa

Improving Quality Through the Emergency General Surgery Verification Program

JAMA Surgery · 2026

Source record (opens in a new tab)

Why this one

Near certain

NewsLink found the paper. Tessa is where you inspect it deeply.

Papers considered

The selected paper, plus nearby candidates.

Crossref · 29 candidate papers

And 23 more candidates considered.